Literature DB >> 2500120

L-arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation.

M E Gold1, K S Wood, G M Buga, R E Byrns, L J Ignarro.   

Abstract

This study examined the actions of L-arginine, a putative precursor of endothelium-derived nitric oxide, and arginine analogs on endothelium-dependent relaxation of isolated rings of bovine pulmonary artery. L-Arginine did not consistently relax arterial rings unless rings were first rendered refractory to endothelium-dependent relaxation by pretreatment with 1 microM A23187 for 45 min. L-Arginine-elicited relaxation was endothelium-dependent, antagonized by oxyhemoglobin or methylene blue, and unaffected by indomethacin. L-Argininosuccinic acid caused endothelium-dependent contractions and irreversible inhibition of endothelium-dependent but not nitroglycerin-elicited relaxation, which was not overcome by addition of L-arginine. Inhibition of endothelium-dependent relaxation by L-NG-monomethyl arginine, however, was reversible and overcome by L-arginine. Therefore, endothelium-dependent relaxants may cause arginine depletion in endothelial cells and endogenous argininosuccinic acid may modulate the biosynthesis of endothelium-derived nitric oxide from arginine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500120     DOI: 10.1016/0006-291x(89)92632-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine.

Authors:  M Hecker; W C Sessa; H J Harris; E E Anggård; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  L-arginine induces relaxation of rat aorta possibly through non-endothelial nitric oxide formation.

Authors:  H Moritoki; H Ueda; T Yamamoto; T Hisayama; S Takeuchi
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

Review 3.  Stimulators and activators of soluble guanylate cyclase for urogenital disorders.

Authors:  Fabiola Z Mónica; Edson Antunes
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

4.  L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits.

Authors:  E Rossitch; E Alexander; P M Black; J P Cooke
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Regulation of baseline vascular resistance in the canine diaphragm by nitric oxide.

Authors:  M E Ward; S N Hussain
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Possible involvement of L-arginine-nitric oxide pathway in modulating regional blood flow to brown adipose tissue of rats.

Authors:  Y Uchida; F Tsukahara; K Irie; T Nomoto; T Muraki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

7.  Reactive nitrogen intermediates, antinuclear antibodies and copper-thionein in serum of patients with rheumatic diseases.

Authors:  R Miesel; M Zuber
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

8.  L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.

Authors:  M A Creager; S J Gallagher; X J Girerd; S M Coleman; V J Dzau; J P Cooke
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  L-arginine and arginine analogues: effects on isolated blood vessels and cultured endothelial cells.

Authors:  H H Schmidt; S E Baeblich; B C Zernikow; M M Klein; E Böhme
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

10.  Endothelium-dependent inhibition of Na(+)-K+ ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium-derived nitric oxide.

Authors:  S Gupta; I Sussman; C S McArthur; K Tornheim; R A Cohen; N B Ruderman
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.